Tuğba Kandemir Gülmez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tuğba Kandemir Gülmez has a total of 308 co-authors. Here are the top co-authors by number of shared publications:
- Ümit Çelik
Department of Pediatric Infectious Diseases, Adana City Training and Research Hospital, University of Health Sciences, Adana, Türkiye
11 shared publications - Elif Afat Turgut
University of Health Sciences, Adana City Training and Research Hospital Department of Pediatric Infectious Diseases Adana
7 shared publications - Merve Kılıç Çil
Department of Pediatric Infectious Diseases, Adana City Training and Research Hospital, University of Health Sciences, Adana, Türkiye
7 shared publications - Ayşe Hitay Telefon
Department of Pediatric Infectious Diseases, Adana City Training and Research Hospital, University of Health Sciences, Adana, Turkey
5 shared publications - Rabia Miray Kisla Ekinci
Department of Pediatric Rheumatology, Çukurova University Faculty of Medicine, Adana, Türkiye
4 shared publications - Ilknur Arslan
Department of Pediatric Intensive Care Unit, Adana City Training and Research Hospital, Adana, Turkey
3 shared publications
Latest Publications
- 28 September 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (10) , 778
Pediatric invasive meningococcal disease in Türkiye during the post-pandemic period: increased reported cases and predominance of serogroup B and severity determined by a clinical form in a multicenter hospital-based cohort
Invasive meningococcal disease (IMD) remains a major cause of morbidity and mortality in children. Post-pandemic epidemiological patterns of pediatric IMD are not well defined in Türkiye. This study aimed to evaluate the epidemiology, clinical characteristics, outcomes, and serogroup distribution of pediatric IMD in a large multicenter cohort in Türkiye, comparing the during-COVID and post-COVID periods. This retrospective multicenter hospital-based study included children aged 1 month–18 years hospitalized with laboratory-confirmed IMD in 39 hospitals across 23 provinces. Cases were grouped as during-COVID (January 2020–May 2022) and post-COVID (June 2022–December 2025). A total of 166 patients (median age 25 months; 59.6% male) were included; 25 occurred during-COVID and 141 post-COVID. The number of reported cases in participating centers increased after 2022, with seasonal peaks in winter and early spring. Children under 5 years accounted for 62.7% of cases, and infants (< 1 year) were the largest single age group overall (38.6%). The proportion of children under 5 years was lower in the post-COVID period (58.9% vs 84.0%; OR 0.27, 95% CI 0.09–0.84), indicating a relative shift toward older age groups rather than a reduction in disease burden among infants. Pediatric intensive care admission occurred in 69.9% of cases, and overall mortality was 13.3%. Mortality varied markedly by clinical form, from 1.2% in meningitis alone to 21.7% in combined meningitis and meningococcemia and 38.1% in meningococcemia alone (p < 0.001). Only 2.4% of children had received any meningococcal vaccine before their illness. Serogroup data were available for 60.8% of patients, with grouping coverage differing between periods (32.0% vs 66.0%). Among cases with available serogroup data, serogroup B accounted for 69.9% in the post-COVID period and for half of the eight grouped cases during the pandemic. In unadjusted exploratory analysis restricted to cases with serogroup data, mortality was higher in serogroup B than non-B infections (21.7% vs 3.1%; OR 8.61, 95% CI 1.08–68.8); in an exploratory model adjusting for clinical form, age, and period, with ungrouped cases retained as a separate category, serogroup B remained associated with mortality (aOR 7.59, 95% CI 1.55–75.65). Conclusion: In this multicenter hospital-based cohort, reported pediatric IMD cases increased in the post-pandemic period, with a persistent burden in infants, a relative shift toward older age groups, and predominance of serogroup B among grouped cases. These findings highlight the importance of strengthened surveillance and support further evaluation of meningococcal vaccination strategies, including MenB vaccination. What is Known: • Invasive meningococcal disease remains a severe pediatric infection with high morbidity and mortality, despite treatment. • The COVID-19 pandemic and the subsequent easing of restrictions altered IMD epidemiology globally. What is New: • Reported pediatric IMD cases increased in the post-pandemic period, with a relative shift toward older children while the proportion of infants remained unchanged (38.3% vs 40.0%); serogroup B predominated among cases with an available serogroup result, although differential availability of these data precludes conclusions about change over time. • Mortality was determined principally by clinical form, ranging from 1.2% in meningitis alone to 38.1% in meningococcemia alone, and only 2.4% of children had received any meningococcal vaccine before their illness.
- 28 September 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (10) , 778
Pediatric invasive meningococcal disease in Türkiye during the post-pandemic period: increased reported cases and predominance of serogroup B and severity determined by a clinical form in a multicenter hospital-based cohort
Invasive meningococcal disease (IMD) remains a major cause of morbidity and mortality in children. Post-pandemic epidemiological patterns of pediatric IMD are not well defined in Türkiye. This study aimed to evaluate the epidemiology, clinical characteristics, outcomes, and serogroup distribution of pediatric IMD in a large multicenter cohort in Türkiye, comparing the during-COVID and post-COVID periods. This retrospective multicenter hospital-based study included children aged 1 month–18 years hospitalized with laboratory-confirmed IMD in 39 hospitals across 23 provinces. Cases were grouped as during-COVID (January 2020–May 2022) and post-COVID (June 2022–December 2025). A total of 166 patients (median age 25 months; 59.6% male) were included; 25 occurred during-COVID and 141 post-COVID. The number of reported cases in participating centers increased after 2022, with seasonal peaks in winter and early spring. Children under 5 years accounted for 62.7% of cases, and infants (< 1 year) were the largest single age group overall (38.6%). The proportion of children under 5 years was lower in the post-COVID period (58.9% vs 84.0%; OR 0.27, 95% CI 0.09–0.84), indicating a relative shift toward older age groups rather than a reduction in disease burden among infants. Pediatric intensive care admission occurred in 69.9% of cases, and overall mortality was 13.3%. Mortality varied markedly by clinical form, from 1.2% in meningitis alone to 21.7% in combined meningitis and meningococcemia and 38.1% in meningococcemia alone (p < 0.001). Only 2.4% of children had received any meningococcal vaccine before their illness. Serogroup data were available for 60.8% of patients, with grouping coverage differing between periods (32.0% vs 66.0%). Among cases with available serogroup data, serogroup B accounted for 69.9% in the post-COVID period and for half of the eight grouped cases during the pandemic. In unadjusted exploratory analysis restricted to cases with serogroup data, mortality was higher in serogroup B than non-B infections (21.7% vs 3.1%; OR 8.61, 95% CI 1.08–68.8); in an exploratory model adjusting for clinical form, age, and period, with ungrouped cases retained as a separate category, serogroup B remained associated with mortality (aOR 7.59, 95% CI 1.55–75.65). Conclusion: In this multicenter hospital-based cohort, reported pediatric IMD cases increased in the post-pandemic period, with a persistent burden in infants, a relative shift toward older age groups, and predominance of serogroup B among grouped cases. These findings highlight the importance of strengthened surveillance and support further evaluation of meningococcal vaccination strategies, including MenB vaccination. What is Known: • Invasive meningococcal disease remains a severe pediatric infection with high morbidity and mortality, despite treatment. • The COVID-19 pandemic and the subsequent easing of restrictions altered IMD epidemiology globally. What is New: • Reported pediatric IMD cases increased in the post-pandemic period, with a relative shift toward older children while the proportion of infants remained unchanged (38.3% vs 40.0%); serogroup B predominated among cases with an available serogroup result, although differential availability of these data precludes conclusions about change over time. • Mortality was determined principally by clinical form, ranging from 1.2% in meningitis alone to 38.1% in meningococcemia alone, and only 2.4% of children had received any meningococcal vaccine before their illness.
- 15 July 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (8) , 576
Clinical characteristics and predictors of severe pertussis in hospitalized children after the COVID-19 period in Türkiye: a multicenter study
Pertussis resurged globally, after the relaxation of COVID-19 measures, underscoring its continued relevance as a public health concern, yet data remain li
- 15 July 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (8) , 576
Clinical characteristics and predictors of severe pertussis in hospitalized children after the COVID-19 period in Türkiye: a multicenter study
Pertussis resurged globally, after the relaxation of COVID-19 measures, underscoring its continued relevance as a public health concern, yet data remain li
- Open Access
- 14 November 2025
- Published by Galenos Yayinevi in Journal of Eurasian Medical Science
Are There Clinical and Laboratory Differences in COVID-19 Infection in Infants and Older Children? Single Center Experience
Are There Clinical and Laboratory Differences in COVID-19 Infection in Infants and Older Children? Single Center Experience - Journal of Eurasian Medical Science
- 14 November 2025
- Published by Galenos Yayinevi in Journal of Eurasian Medical Science
Open AccessAre There Clinical and Laboratory Differences in COVID-19 Infection in Infants and Older Children? Single Center Experience
Are There Clinical and Laboratory Differences in COVID-19 Infection in Infants and Older Children? Single Center Experience - Journal of Eurasian Medical Science
- 27 June 2025
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 19 (2) , 95-102
İki Yıllık Multisistem Enflamatuvar Sendrom Deneyimi: Pandemi Başından İtibaren Neler Değişti?
- 27 June 2025
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 19 (2) , 95-102
İki Yıllık Multisistem Enflamatuvar Sendrom Deneyimi: Pandemi Başından İtibaren Neler Değişti?
- 27 June 2025
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 19 (2) , 97-104
A Two-Year Multisystem Inflammatory Syndrome Experience: What has Changed Since the Beginning of the Pandemic?
- 27 June 2025
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 19 (2) , 97-104
A Two-Year Multisystem Inflammatory Syndrome Experience: What has Changed Since the Beginning of the Pandemic?
- 27 June 2025
- Published by Springer Nature in Pediatric Nephrology
- Vol. 40 (11) , 3529-3537
Dysnatremias in pediatric victims of the 2023 Türkiye–Syria earthquake
Background Dysnatremia is a common electrolyte abnormality in children, but its prevalence and impact in pediatric earthquake victims are not well established. This study aimed to define the frequency of dysnatremia in pediatric earthquake victims and evaluate its relationship with complications, mortality, and morbidity. Methods We retrospectively analyzed data from 312 pediatric patients admitted to our hospital after the 2023 Türkiye–Syria earthquakes. Patients were categorized based on admission sodium levels: hyponatremic (< 135 mmol/L), hypernatremic (> 145 mmol/L), and normal (135–145 mmol/L). Demographic, clinical, and laboratory data were analyzed. Results Of the 312 patients, 36.2% were hyponatremic, 17.3% were hypernatremic, and 46.5% had normal sodium levels. The frequency of fasciotomy, crush syndrome (CS), acute kidney injury (AKI), and dialysis treatment was significantly higher in the hyponatremic patient group compared to those with normal sodium levels (p < 0.001). Hypernatremic patients also had a longer time under the rubble at 121 ± 64 h, compared to 35 ± 41 h in patients with normal sodium (p < 0.001). Mortality was 5.4%, with no significant difference between dysnatremic and normonatremic patients. Conclusions Dysnatremia is common in pediatric earthquake victims. Dysnatremia is associated with increased morbidity, including CS and AKI. Monitoring and management of sodium abnormalities are crucial in the care of pediatric earthquake survivors. Graphical abstract A higher resolution version of the Graphical abstract is available as Supplementary information
- 27 June 2025
- Published by Springer Nature in Pediatric Nephrology
- Vol. 40 (11) , 3529-3537
Dysnatremias in pediatric victims of the 2023 Türkiye–Syria earthquake
Background Dysnatremia is a common electrolyte abnormality in children, but its prevalence and impact in pediatric earthquake victims are not well established. This study aimed to define the frequency of dysnatremia in pediatric earthquake victims and evaluate its relationship with complications, mortality, and morbidity. Methods We retrospectively analyzed data from 312 pediatric patients admitted to our hospital after the 2023 Türkiye–Syria earthquakes. Patients were categorized based on admission sodium levels: hyponatremic (< 135 mmol/L), hypernatremic (> 145 mmol/L), and normal (135–145 mmol/L). Demographic, clinical, and laboratory data were analyzed. Results Of the 312 patients, 36.2% were hyponatremic, 17.3% were hypernatremic, and 46.5% had normal sodium levels. The frequency of fasciotomy, crush syndrome (CS), acute kidney injury (AKI), and dialysis treatment was significantly higher in the hyponatremic patient group compared to those with normal sodium levels (p < 0.001). Hypernatremic patients also had a longer time under the rubble at 121 ± 64 h, compared to 35 ± 41 h in patients with normal sodium (p < 0.001). Mortality was 5.4%, with no significant difference between dysnatremic and normonatremic patients. Conclusions Dysnatremia is common in pediatric earthquake victims. Dysnatremia is associated with increased morbidity, including CS and AKI. Monitoring and management of sodium abnormalities are crucial in the care of pediatric earthquake survivors. Graphical abstract A higher resolution version of the Graphical abstract is available as Supplementary information
- 10 June 2025
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 119 (10) , 1207-1210
Utility of anakinra in Crimean Congo haemorrhagic fever with haemophagocyctic lymphohistiocytosis: a case report
Crimean Congo haemorrhagic fever (CCHF) is an emerging, life-threatening tick-borne infection that can be fatal. As yet, there is no definitive treatment. In this case report we present a severe paediatric CCHF case that was successfully treated with anakinra. A previously healthy 13-year-old female presented with high fever, fatigue, rash and loss of appetite. Bone marrow aspiration showed rare haemophagocytocis and the patient's clinical condition continued to deteriorate. Anakinra was given on the day 5 of admission, as she was in the midst of cytokine storm syndrome. By the third day of anakinra, the patient's symptoms and laboratory tests improved. After 14 d of anakinra, she was discharged in full recovery. Anakinra may be a new therapeutic agent in CCHF, in which inflammation plays important role.
- 10 June 2025
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 119 (10) , 1207-1210
Utility of anakinra in Crimean Congo haemorrhagic fever with haemophagocyctic lymphohistiocytosis: a case report
Crimean Congo haemorrhagic fever (CCHF) is an emerging, life-threatening tick-borne infection that can be fatal. As yet, there is no definitive treatment. In this case report we present a severe paediatric CCHF case that was successfully treated with anakinra. A previously healthy 13-year-old female presented with high fever, fatigue, rash and loss of appetite. Bone marrow aspiration showed rare haemophagocytocis and the patient's clinical condition continued to deteriorate. Anakinra was given on the day 5 of admission, as she was in the midst of cytokine storm syndrome. By the third day of anakinra, the patient's symptoms and laboratory tests improved. After 14 d of anakinra, she was discharged in full recovery. Anakinra may be a new therapeutic agent in CCHF, in which inflammation plays important role.
- 29 April 2025
- Published by Academician Publishing
- p. 171-178
Konjenital Enfeksiyonların Görüntüleme Bulguları
- 29 April 2025
- Published by Academician Publishing
- p. 171-178
Konjenital Enfeksiyonların Görüntüleme Bulguları
- 29 April 2025
- Published by Academician Publishing
- p. 73-80
İlaç Ateşi
İlaç ateşi dikkatli bir klinik öykü, fizik muayene ve laboratuvar tetkiklerine rağmen sebebin bulunulamadığı; ilacın uygulanması ile çakışan ve kesilmesinden sonraki 48-72 saat içinde düzelen bir advers ilaç reaksiyonudur. İnsidansının %3 ile %5 arasında olduğu tahmin edilmektedir ve hastanede yatan hastaların yaklaşık %10’unda ateşin sebebi olarak düşünülmektedir. İlaç ateşinin nedeni çok çeşitlidir ve patofizyolojik olarak beş temel mekanizma neticesinde ateşe neden olabilir. Bunlar değişen termoregülatör mekanizmalar, hipersensitivite reaksiyonları, idiyosenkratik (ilaca özgü) reaksiyonlar, ilaç uygulamasına bağlı reaksiyonlar ve ilacın doğrudan farmakolojik etkisinin uzantısı olan reaksiyonlar olarak sınıflandırılmıştır. İlaçlara bağlı gelişen ateş tedavi altındaki hastalarda herhangi bir zamanda ortaya çıkabilmekle beraber en sık olarak tedavinin 7-10. günlerinde karşımıza çıkar. İlaç ateşi tanısı sıklıkla zordur ve hastanın klinik tablosu, laboratuvar tetkikleri ve verilen tedaviler dikkatlice incelendikten sonra dışlama tanısı olarak konulur. Hastanın klinik olarak iyi olduğu bir durumda ortaya çıkan ateşte özellikle de ilaç ateşine neden olma ihtimali yüksek bir ajan kullanıyorsa tanı olarak ön planda düşünülmelidir. Tedavi için en mantıklı yaklaşım; uygunsa en çok rahatsız edici ilacın kesilmesidir. İlaç ateşinin prognozu iyidir.
- 29 April 2025
- Published by Academician Publishing
- p. 73-80
İlaç Ateşi
İlaç ateşi dikkatli bir klinik öykü, fizik muayene ve laboratuvar tetkiklerine rağmen sebebin bulunulamadığı; ilacın uygulanması ile çakışan ve kesilmesinden sonraki 48-72 saat içinde düzelen bir advers ilaç reaksiyonudur. İnsidansının %3 ile %5 arasında olduğu tahmin edilmektedir ve hastanede yatan hastaların yaklaşık %10’unda ateşin sebebi olarak düşünülmektedir. İlaç ateşinin nedeni çok çeşitlidir ve patofizyolojik olarak beş temel mekanizma neticesinde ateşe neden olabilir. Bunlar değişen termoregülatör mekanizmalar, hipersensitivite reaksiyonları, idiyosenkratik (ilaca özgü) reaksiyonlar, ilaç uygulamasına bağlı reaksiyonlar ve ilacın doğrudan farmakolojik etkisinin uzantısı olan reaksiyonlar olarak sınıflandırılmıştır. İlaçlara bağlı gelişen ateş tedavi altındaki hastalarda herhangi bir zamanda ortaya çıkabilmekle beraber en sık olarak tedavinin 7-10. günlerinde karşımıza çıkar. İlaç ateşi tanısı sıklıkla zordur ve hastanın klinik tablosu, laboratuvar tetkikleri ve verilen tedaviler dikkatlice incelendikten sonra dışlama tanısı olarak konulur. Hastanın klinik olarak iyi olduğu bir durumda ortaya çıkan ateşte özellikle de ilaç ateşine neden olma ihtimali yüksek bir ajan kullanıyorsa tanı olarak ön planda düşünülmelidir. Tedavi için en mantıklı yaklaşım; uygunsa en çok rahatsız edici ilacın kesilmesidir. İlaç ateşinin prognozu iyidir.
- Open Access
- 29 April 2025
- Published by Academician Publishing
Çocukluk Çağında Ateş ve İlişkili Hastalıklar
Ateşin Tanımı ve Tipleri Nahide HAYKIR Ateşin Patofizyolojisi Görkem ŞAHİN Ateş Ölçüm Yöntemleri Yunus Emre İNCE Ateşin Düşürülmesi ve Kullanılan İlaçlar Mehmet ALMACIOĞLU Odağı Bilinmeyen Ateş Özlem ÖZGÜR GÜNDEŞLİOĞLU Nedeni Bilinmeyen Ateş Melis AKPINAR Santral Ateş Saliha YAVUZ ERAVCI İlaç Ateşi Elif AFAT Tuğba KANDEMİR GÜLMEZ İnfluenza Ümmühan ÇAY Akut Nazofarenjit Saliha BARUTÇU Adnan BARUTÇU Akut Tonsillofarenjit İsmail BULUT Yunus Emre BULUT Akut Otitis Media Fevziye BAŞKAN Akut Rinosinüzit Merve KİŞİOĞLU Zeynep Gökçe GAYRETLİ AYDIN Krup Sendromları Adnan BARUTÇU Akut Bronşiolit Abdullah SOLMAZ Filiz SOLMAZ Pnömoni Aysel Burcu İBİLİ Akut Viral Gastroenteritler Sevinç GARİP Akut Bakteriyel Gastroenteritler Abdul Samet ALA Cilt Ve Yumuşak Doku Enfeksiyonları Erdal SARI Döküntülü Hastalıklar Saliha BARUTÇU Sepsis Gözde ATASEVER YILDIRIM Septik Artrit Nisa Nur TAPAÇ Osteomiyelit Asena ÜNAL Akut Bakteriyel Menenjit Merve İŞERİ NEPESOV Akut Viral Menenjit Mehtap AKÇA İdrar Yolu Enfeksiyonu Aylin GENÇLER Epstein-Barr Virüs Enfeksiyonları Asena ÜNAL Salmonella Güldane DİKME Bruselloz Zeynep SAVAŞ ŞEN Visseral Leishmaniasis Melis DENİZ Sıtma (Malarya) Ayşe Hitay TELEFON Merve KILIÇ ÇİL Tüberküloz Fatma Tuğba ÇETİN Lyme Hastalığı Fatma KILINÇ Leptospiroz Özhan ORHAN Kedi Tırmığı Hastalığı Mahmut Can KIZIL Tularemi Ali Emre ÇETİNKOL Riketsiyal Hastalıklar Pınar BAYRAKTAR Q Ateşi Özlem MUSTAFAOĞLU Viral Kanamalı Ateşler Ulaş ÖZDEMİR Ümit ÇELİK Periyodik Ateş Sendromları Furkan KALAYCI Sistemik Juvenil İdiyopatik Artrit Sema Nur TAŞKIN Kawasaki Hastalığı Şeyda DOĞANTAN Febril Konvülziyon Zeliha HAYTOĞLU Febril Nötropeni Yalçın KARA Kemoterapi İlişkili Olmayan Nötropeni Necla İPAR Orak Hücre Anemisi Metin YİĞİT Dalak Yokluğu ve Fonksiyon Bozukluğunda Ateş Gökçe OĞUZ Çocuklarda Malignite ve Ateş Ömer OKUYAN Yoğunbakımda Ateş ve Yönetimi Hasan Ali TELEFON Postoperatif Ateş Enes Kaan KILIÇ İnfektif Endokardit Hüseyin ELÇİ Akut Romatizmal Ateş Anıl ATMIŞ Seyahatten Sonra Ateş Emel BAKANOĞLU Renal Apse Zahide ORHAN OK
- 29 April 2025
- Published by Academician Publishing
Open AccessÇocukluk Çağında Ateş ve İlişkili Hastalıklar
Ateşin Tanımı ve Tipleri Nahide HAYKIR Ateşin Patofizyolojisi Görkem ŞAHİN Ateş Ölçüm Yöntemleri Yunus Emre İNCE Ateşin Düşürülmesi ve Kullanılan İlaçlar Mehmet ALMACIOĞLU Odağı Bilinmeyen Ateş Özlem ÖZGÜR GÜNDEŞLİOĞLU Nedeni Bilinmeyen Ateş Melis AKPINAR Santral Ateş Saliha YAVUZ ERAVCI İlaç Ateşi Elif AFAT Tuğba KANDEMİR GÜLMEZ İnfluenza Ümmühan ÇAY Akut Nazofarenjit Saliha BARUTÇU Adnan BARUTÇU Akut Tonsillofarenjit İsmail BULUT Yunus Emre BULUT Akut Otitis Media Fevziye BAŞKAN Akut Rinosinüzit Merve KİŞİOĞLU Zeynep Gökçe GAYRETLİ AYDIN Krup Sendromları Adnan BARUTÇU Akut Bronşiolit Abdullah SOLMAZ Filiz SOLMAZ Pnömoni Aysel Burcu İBİLİ Akut Viral Gastroenteritler Sevinç GARİP Akut Bakteriyel Gastroenteritler Abdul Samet ALA Cilt Ve Yumuşak Doku Enfeksiyonları Erdal SARI Döküntülü Hastalıklar Saliha BARUTÇU Sepsis Gözde ATASEVER YILDIRIM Septik Artrit Nisa Nur TAPAÇ Osteomiyelit Asena ÜNAL Akut Bakteriyel Menenjit Merve İŞERİ NEPESOV Akut Viral Menenjit Mehtap AKÇA İdrar Yolu Enfeksiyonu Aylin GENÇLER Epstein-Barr Virüs Enfeksiyonları Asena ÜNAL Salmonella Güldane DİKME Bruselloz Zeynep SAVAŞ ŞEN Visseral Leishmaniasis Melis DENİZ Sıtma (Malarya) Ayşe Hitay TELEFON Merve KILIÇ ÇİL Tüberküloz Fatma Tuğba ÇETİN Lyme Hastalığı Fatma KILINÇ Leptospiroz Özhan ORHAN Kedi Tırmığı Hastalığı Mahmut Can KIZIL Tularemi Ali Emre ÇETİNKOL Riketsiyal Hastalıklar Pınar BAYRAKTAR Q Ateşi Özlem MUSTAFAOĞLU Viral Kanamalı Ateşler Ulaş ÖZDEMİR Ümit ÇELİK Periyodik Ateş Sendromları Furkan KALAYCI Sistemik Juvenil İdiyopatik Artrit Sema Nur TAŞKIN Kawasaki Hastalığı Şeyda DOĞANTAN Febril Konvülziyon Zeliha HAYTOĞLU Febril Nötropeni Yalçın KARA Kemoterapi İlişkili Olmayan Nötropeni Necla İPAR Orak Hücre Anemisi Metin YİĞİT Dalak Yokluğu ve Fonksiyon Bozukluğunda Ateş Gökçe OĞUZ Çocuklarda Malignite ve Ateş Ömer OKUYAN Yoğunbakımda Ateş ve Yönetimi Hasan Ali TELEFON Postoperatif Ateş Enes Kaan KILIÇ İnfektif Endokardit Hüseyin ELÇİ Akut Romatizmal Ateş Anıl ATMIŞ Seyahatten Sonra Ateş Emel BAKANOĞLU Renal Apse Zahide ORHAN OK